Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes-Reference-Cited by-同舟云学术

Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes

Published:2016-05-03 Issue:18 Volume:7 Page:26422-26435
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yang Zhang-Ru¹²,Zhao Ning²,Meng Jin²,Shi Ze-Liang²,Li Bing-Xin²,Wu Xian-Wei³,Li Ping³,Zhang Qing³,Wei Xun-Bin¹,Fu Shen²³

Affiliation:

1. State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China

2. Department of Radiation Oncology, Shanghai Sixth People's Hospital of Jiao Tong University, Shanghai, China

3. Radiation Oncology Center, Fudan University Shanghai Cancer Center (FUSCC), Shanghai Proton and Heavy Ion Center (SPHIC), Shanghai, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer;Radiotherapy and Oncology;2024-06

2. Peripheral Blood Lymphocyte Subsets and Long-Term Clinical Outcomes in Prostate Cancer Patients: An Eight- Year Follow-up Study;2024-05-31

3. A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-cox regression;BMC Cancer;2024-02-23

4. Brachytherapy for high grade prostate cancer induces distinct changes in circulating CD4 and CD8 T cells – Implications for systemic control;Radiotherapy and Oncology;2024-02

5. The Correlation Between Low-Dose Radiotherapy Area of the Mediastinum and CD8+T Cells and the Efficacy of Radiotherapy for Non-Small Cell Lung Cancer;Cancer Management and Research;2024-01